BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22250051)

  • 1. Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.
    Dutton-Regester K; Aoude LG; Nancarrow DJ; Stark MS; O'Connor L; Lanagan C; Pupo GM; Tembe V; Carter CD; O'Rourke M; Scolyer RA; Mann GJ; Schmidt CW; Herington A; Hayward NK
    Genes Chromosomes Cancer; 2012 May; 51(5):452-61. PubMed ID: 22250051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Stark M; Hayward N
    Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
    Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
    Walker GJ; Flores JF; Glendening JM; Lin AH; Markl ID; Fountain JW
    Genes Chromosomes Cancer; 1998 Jun; 22(2):157-63. PubMed ID: 9598804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
    Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
    Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
    Jönsson G; Busch C; Knappskog S; Geisler J; Miletic H; Ringnér M; Lillehaug JR; Borg A; Lønning PE
    Clin Cancer Res; 2010 Jul; 16(13):3356-67. PubMed ID: 20460471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
    Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PTEN mutations in metastatic melanoma specimens.
    Celebi JT; Shendrik I; Silvers DN; Peacocke M
    J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.
    Soto Martínez JL; Cabrera Morales CM; Serrano Ortega S; López-Nevot MA
    Clin Transl Oncol; 2005 May; 7(4):156-64. PubMed ID: 15960923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
    Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.
    Liu W; Xie CC; Zhu Y; Li T; Sun J; Cheng Y; Ewing CM; Dalrymple S; Turner AR; Sun J; Isaacs JT; Chang BL; Zheng SL; Isaacs WB; Xu J
    Neoplasia; 2008 Aug; 10(8):897-907. PubMed ID: 18670647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma.
    Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
    Arch Dermatol Res; 1998 Apr; 290(4):175-80. PubMed ID: 9617435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.
    Solomon DA; Kim JS; Cronin JC; Sibenaller Z; Ryken T; Rosenberg SA; Ressom H; Jean W; Bigner D; Yan H; Samuels Y; Waldman T
    Cancer Res; 2008 Dec; 68(24):10300-6. PubMed ID: 19074898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
    Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
    Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
    Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.
    Conway C; Beswick S; Elliott F; Chang YM; Randerson-Moor J; Harland M; Affleck P; Marsden J; Sanders DS; Boon A; Knowles MA; Bishop DT; Newton-Bishop JA
    Genes Chromosomes Cancer; 2010 May; 49(5):425-38. PubMed ID: 20140953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.